New research being presented at the ESCMID Global Congress shows that ChatGPT, a free-to-use, and widely accessible AI-powered chatbot, could be an effective tool in reducing vaccine hesitancy among the general public.
Even though AI chatbots like ChatGPT were introduced in late 2022, they have been struggling with accuracy issues.
Furthermore, individuals who mistrust health professionals may use technology to address their concerns.
Read More
